Effects of antidiabetic drug metformin on the migration and invasion abilities of human pulmonary adenocarcinoma A549 cell line in vitro

Journal of Thoracic Disease

Volumn 2, Issue 2, 2010, Pages 76-80

  Wu, Ning ^a,b   Gu, Hong Jun ^a,b   Li, Qiang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Internal Medicine   (China)

Author keywords

Invasion ability; Metformin; Migration; MMP2; MMP9; Pulmonary adenocarcionma

Indexed keywords

EID: 80052712693     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334:574-9.
2. Hadad SM, Appleyard V, Thompson AM. Therapeutic metformin/ AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Res Treat 2009; 114:391.
3. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001;108:1167-74.
4. Li J, Jiang P, Robinson M, Lawrence TS, Sun Y. AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression. Carcinogenesis2003;24:827-34.
5. Hadad SM, Fleming S, Thompson AM. Targeting AMPK: A new therapeutic opportunity in breast cancer. Crit Rev Oncol Hematol 2008; 67:1-7.
6. Ben Sahra I, Laurent K, Loubat A, Giorgetti-Peraldi S, Colosetti P, Auberger P, et al. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene 2008;27:3576-86.
7. Buzzai M, Jones RG, Amaravadi RK, Lum JJ, DeBerardinis RJ, Zhao F, et al. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 2007;67:6745-52.
8. Gotlieb WH, Saumet J, Beauchamp MC, Gu J, Lau S, Pollak MN, Bruchim I. In vitro metformin anti-neoplastic activity in epithelial ovarian cancer. Gynecol Oncol 2008;110:246-50.
9. Wu N, Gu HJ, Yin HJ, Li Q. Effects of antidiabetic drug metformin on human lung adenocarcinoma cell A549 proliferation and apoptosis in vitro. China Oncology 2009; 19:21-4.
10. Erik S. Mechanisms of cancer cell invasion. Curr Opin Genet Dev 2005; 15:87-96.
11. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89:1260-70.
12. González-Avila G, Iturria C, Vadillo F, Terán L, Selman M, Pérez-Tamayo R. 72-kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells. Pathobiology 1998;66:5-16.
13. Ylisirniö S, Höyhtyä M, Turpeenniemi-Hujanen T. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer-TIMP-1 as a prognostic marker. Anticancer Res 2000;20:1311-6.